Q4 2014

Source filing unavailable

Q4 2014 · —

derived · Computed from the longer spans the company filed.

Revenue

$16.11M

derivedno prior Q4 2013 on file

Net Income

-$50.56M

derivedno prior Q4 2013 on file

EPS, diluted—Not derived. Share counts vary by quarter.

Operating Incomederived-$47,974,000—

Same quarter

no prior Q4 2013 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Kyntra Bio, Inc. · CIK 921299 · Engraved from SEC EDGAR